Medical Devices
AI
Technology
Science Corp Prepares First Brain Implant Trials with Reversible Neuron-Grown Interface
Max Hodak's $1.5B neurotech firm enlists Yale surgeon for 2027 human trials of biohybrid system that avoids tissue damage while commercializing vision-restoration device
AI
Geopolitics
China Claims First Commercial Brain Implant Approval, Escalating Neurotechnology Race with US
Beijing's regulatory fast-track for Neuracle's invasive device marks strategic bid to control dual-use technology with military and surveillance applications.
Technology
Science Corp Emerges as Neuralink Rival With Vision-Restoring Brain Implant
Max Hodak's neurotech startup is advancing brain-computer interfaces through medical applications while competitors race for broader consumer adoption.